Zenzedi
NDC 24338-855, Dextroamphetamine Sulfate, tablet, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 24338-855
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090533
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/24338-855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROAMPHETAMINE SULFATE20 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24338-855-03 | 24338085503 | 30 TABLET in 1 BOTTLE (24338-855-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d6394df5-f2c9-47eb-b57e-f3e9cfd94f84
Use it
Look up 24338-855 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24338-855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24338-855. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.